These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 21896610)
1. Evidence of comparative efficacy should have a formal role in European drug approvals. Sorenson C; Naci H; Cylus J; Mossialos E BMJ; 2011 Sep; 343():d4849. PubMed ID: 21896610 [No Abstract] [Full Text] [Related]
2. A new approach to drug development. Mayer D N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099949 [No Abstract] [Full Text] [Related]
3. The marketplace can't give us the drug safety data we need. Avorn J MedGenMed; 2007 Feb; 9(1):29. PubMed ID: 17435636 [No Abstract] [Full Text] [Related]
4. Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe. Boon WP; Moors EH; Meijer A; Schellekens H Clin Pharmacol Ther; 2010 Dec; 88(6):848-53. PubMed ID: 20962774 [TBL] [Abstract][Full Text] [Related]
5. Commentary: The balance between marketing and safety. Beard K BMJ; 2008 Dec; 337():a2996. PubMed ID: 19109322 [No Abstract] [Full Text] [Related]
9. Viewpoint: Sir Richard Sykes, DSc, FRS, FMedSci. Interview by Ingrid Torjesen, BSc. Sykes R Circulation; 2006 Jun; 113(22):f85-6. PubMed ID: 16754809 [No Abstract] [Full Text] [Related]
10. Recent drug approvals from the US FDA and EMEA: what the future holds. Pevarello P Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069 [TBL] [Abstract][Full Text] [Related]
11. Quicker drug approvals on the way for Europe. Davidson S Nat Biotechnol; 2001 Sep; 19(9):798-9. PubMed ID: 11533626 [No Abstract] [Full Text] [Related]
12. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role]. Ainsworth MA Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819 [TBL] [Abstract][Full Text] [Related]
13. Drug evaluation and approval process in the European Union. San Miguel MT; Vargas E Arthritis Rheum; 2006 Feb; 55(1):12-4. PubMed ID: 16463405 [No Abstract] [Full Text] [Related]
14. Former pharma pitchman: beware of new drugs. An industry insider advises considering the older options if you need a prescription. Interview by Sarah Baldauf. Nesi T US News World Rep; 2008 Nov 3-10; 145(10):64. PubMed ID: 18998444 [No Abstract] [Full Text] [Related]
15. Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs. Reed SD; Anstrom KJ; Seils DM; Califf RM; Schulman KA Health Aff (Millwood); 2008; 27(5):w360-70. PubMed ID: 18682441 [TBL] [Abstract][Full Text] [Related]